Loading company…
Tethis S.p.A. develops liquid biopsy solutions that process biological samples for cancer diagnostics, based in Milan.
Founded in Milan, Italy, Tethis S.p.A. develops liquid biopsy solutions that process samples immediately and in an automated way to keep them intact for cancer diagnostics. Paolo Milani, the founder, has a background in healthcare innovation, and Daniele Scarinci is CEO, alongside Holger Neecke. In January 2025 the company raised EUR 15 million in venture funding, co-led by Fondazione ENEA Tech e Biomedical and Biomedical Foundation, after 2 funding deals. The listed stage is Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in